PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Inc., the U.S. arm of Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company headquartered in Hyderabad, India, today announced the launch of a comprehensive employee support program focused on menopause awareness, benefits, and training, in alignment with Menopause Awareness Month this October.

新泽西州普林斯顿讯（商业新闻短讯）--总部位于印度海得拉巴的全球制药公司Reddy's Laboratories Ltd.的美国分公司Reddy's Laboratories Inc.今天宣布推出一项全面的员工支持计划，重点是更年期意识，福利和培训，与今年10月的更年期意识月保持一致。

This initiative underscores the company’s commitment to fostering an inclusive and supportive work environment by addressing the unique needs of its employees who are and will experience menopause..

这一举措强调了公司致力于通过满足正在经历和即将经历更年期的员工的独特需求，营造一个包容和支持的工作环境。。

“As a company deeply invested in the well-being of our employees, we recognize that menopause is a significant phase in many of our employees' lives,” says Ashish Girotra, Vice President, Self-Care and Wellness Division at Dr. Reddy’s North America. “By launching this program during Menopause Awareness Month, we aim to break the stigma around menopause in the workplace and ensure that all our employees feel supported and empowered during this time,” he added..

Reddy博士北美公司自我保健和健康部副总裁Ashish Girotra说：“作为一家对员工福祉进行了深入投资的公司，我们认识到更年期是许多员工生活中的重要阶段。”。他补充道：“通过在更年期意识月期间启动这一计划，我们的目标是打破工作场所对更年期的污名，并确保我们所有的员工在此期间都感到得到支持和授权。”。。

A Groundbreaking Step in Employee Wellness-

-

Recognizing the challenges that menopause can present in the workplace, Dr. Reddy’s menopause support program goes beyond traditional employee healthcare benefits. The new program includes:

认识到更年期可能在工作场所带来的挑战，雷迪博士的更年期支持计划超越了传统的员工医疗福利。新计划包括：

Enhanced Health Benefits: The program expands the company’s healthcare offerings to cover a broader range of menopause-related treatments and services. This includes coverage for hormone replacement therapy (HRT), counseling, pelvic floor therapy, unlimited sick leave, acupuncture, on-line therapy resources, and access to specialized healthcare professionals..

增强健康益处：该计划扩大了公司的医疗保健服务范围，涵盖了更广泛的更年期相关治疗和服务。。。

Menopause Education and Training: All employees and company leaders will have access to a comprehensive training session slated for Wednesday, October 15, 2024. The half-day training event, hosted by internationally renowned menopause advocacy organization, Over the Bloody Moon, will focus on understanding menopause, its impact on employees, and how to create a supportive workplace culture.

更年期教育和培训：所有员工和公司领导都将参加定于2024年10月15日（星期三）举行的综合培训课程。这项为期半天的培训活动由国际知名的更年期倡导组织The Bloody Moon主办，重点是了解更年期及其对员工的影响，以及如何创造一种支持性的工作场所文化。

The training session will feature MenoVest™, a wearable interactive menopause simulator designed to drive engagement and allyship..

培训课程将以MenoVest™为特色，这是一款可穿戴的交互式更年期模拟器，旨在推动参与和allyship。。

Flexible Work Arrangements: The program introduces flexible working options for employees experiencing menopause, including adjusted work hours and remote work opportunities, to accommodate their health and well-being.

灵活的工作安排：该计划为经历更年期的员工引入了灵活的工作选择，包括调整工作时间和远程工作机会，以适应他们的健康和福祉。

Support Groups and Resources: To further the efforts of the program, the company has established support groups, both in-person and virtual, where employees can share experiences and advice. Additionally, a dedicated resource hub through the company’s subsidiary, MenoLabs, is available, offering information, guidance, and products on managing menopause..

支持小组和资源：为了进一步推动该计划的努力，公司建立了个人和虚拟支持小组，员工可以在那里分享经验和建议。此外，通过该公司的子公司MenoLabs，还有一个专门的资源中心，提供有关管理更年期的信息、指导和产品。。

………………………………………………………………………………………………………………………………………………………………………………………………………

………………………………………………………………………………………………………………………………………………………………………………………………………

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

关于Reddy博士：Reddy博士实验室有限公司（BSE:500124，NSE:DRREDDY，NYSE:RDY，NSEIFSC:DRREDDY）是一家全球制药公司，总部位于印度海得拉巴。我们成立于1984年，致力于提供负担得起的创新药物。本着“健康不能等待”的宗旨，我们提供了一系列产品和服务，包括API、仿制药、品牌仿制药、生物仿制药和OTC。

Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future.

我们的主要治疗领域是胃肠道，心血管，糖尿病，肿瘤学，疼痛管理和皮肤病学。我们的主要市场包括美国、印度、俄罗斯和独联体国家、中国、巴西和欧洲。作为一家拥有深厚科学历史并创造了多个行业第一的公司，我们将继续向前规划并投资于未来的业务。

As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com..

作为可持续发展和ESG行动的早期采用者，我们于2004年发布了第一份可持续发展报告。我们目前的ESG目标旨在为环境管理设定更高的标准；患者的获取和负担能力；多样性；和治理。。。

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management’s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements.

免责声明：本新闻稿可能包括未来预期声明和其他前瞻性声明，这些声明基于管理层当前的观点和假设，涉及已知或未知的风险和不确定性，可能导致实际结果、绩效或事件与此类声明中明示或暗示的结果、绩效或事件存在重大差异。

In addition to statements which are forward-looking by reason of context, the words 'may', 'will', 'should', 'expects', 'plans', 'intends', 'anticipates', 'believes', 'estimates', 'predicts', 'potential', or 'continue' and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers’, products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the 'Risk Factors' and 'Forward-Looking Statements' sections of our Annual Report on Form 20-F for the year ended March 31, 2024.

除了因上下文而具有前瞻性的陈述外，“可能”、“将”、“应该”、“期望”、“计划”、“打算”、“预期”、“相信”、“估计”、“预测”、“潜在”或“继续”等词语以及类似的表达也可以识别前瞻性陈述。实际结果、表现或事件可能与此类报表中的结果、表现或事件存在重大差异，原因包括但不限于：（i）一般经济状况，如金融市场表现、信用违约、货币汇率、利率、持续性水平和投保损失事件的频率/严重程度；（ii）死亡率和发病率水平和趋势；（iii）竞争水平和一般竞争因素的变化；（iv）法律法规和央行和/或政府政策的变化；（v）收购或重组的影响，包括相关的整合问题；以及（vi）我们的行业和我们以及我们的客户的产品和服务所涉及的市场对自然灾害、流行病、流行病或其他广泛疾病导致的经济衰退的敏感性包括冠状病毒（或新型冠状病毒），以及（vii）我们向证券交易委员会提交的公开文件中确定的其他风险和不确定性，包括截至2024年3月31日的20-F表年度报告中“风险因素”和“前瞻性陈述”部分所列的因素。

Th.

第。